Neolytica - A QPharma Company
Achelle Paul currently serves as the Vice President of Data and Research at Neolytica, a QPharma Company, since December 2020. Prior to this role, Achelle Paul held various positions at 81qd from January 2010 to December 2020, including Director of Research and Data Quality, Supervisor of Scientific Affairs, Associate Director of Medical and Scientific Affairs, and Associate Medical Strategist. Previously, Achelle Paul worked as a Research Scientist at Albert Einstein College of Medicine from April 2009 to December 2009. Achelle Paul earned a PhD in Biomedical Sciences with a focus on Biochemistry from Albert Einstein College of Medicine between 2004 and 2009 and completed a Bachelor of Science in Chemistry at Morgan State University from 2000 to 2004.
Neolytica - A QPharma Company
A subsidiary of QPharma, Neolytica brings solutions and a portfolio of products that leverage cutting edge technologies like AI and Data Analytics to deliver significant value in strategic and operational aspects of Medical Affairs, Market Access, Commercial Marketing and Commercial Sales. Our offerings portfolio includes: Ti Expert : This technology and consulting solution brings comprehensive access to data about highly qualified and validated medical professionals, including professional spheres of influence, social relationships, and promotional activities. NotifyMe : A Healthcare KOL engagement service with email alerts. An application that enables enterprise-scale social listening and provides actionable alerts on healthcare stakeholders in a desired therapeutic area. Ti Risk : Dependence on Opioid has increased burden on patients, employers, insurers, society, and the health care system. Our product aims to address this by identifying prescribers and patients that are potentially involved in diversion of opioids by following patient journey and prescriber behaviour, along with supplementary secondary research – Real-time and At-risk scoring analysis. For more details, visit - www.neolytica.ai